MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression
Open Access
- 2 July 2016
- journal article
- research article
- Published by Springer Nature in Chinese Journal of Cancer
- Vol. 35 (1) , 1-7
Abstract
MicroRNA-506 (miR-506) has been reported to function in several tumors as a tumor suppressor gene or oncogene. However, the expression and role of miR-506 in pancreatic ductal adenocarcinoma (PDAC) remains unclear. In this study, we aimed to evaluate the phenotype of miR-506 in PDAC. Using miRNA in situ hybridization, we examined the expression of miR-506 in 113 PDACs and 87 paired normal pancreatic tissues. We evaluated miR-506 expression in PDAC cells, normal pancreatic ducts, and acinus/islands, and we analyzed the associations between miR-506 expression and the clinicopathologic characteristics of PDAC patients. miR-506 expression was higher in PDAC than in matched normal pancreatic ductal cells (P < 0.001). On the other hand, the combined group of well and moderately differentiated PDACs showed higher levels of miR-506 than the poorly differentiated ones (P = 0.023). Moreover, miR-506 expression was negatively associated with pathologic T category (P = 0.004) and lymph node metastasis (P = 0.033), suggesting that miR-506 might inhibit the progression of PDAC. Our results suggest that miR-506 either plays a role as an oncogene in the tumorigenesis and a tumor suppressor in the progression or serves as a house-keeping, tumor-suppressing miRNA, whose expression can be activated by oncogenic signals in early development to hinder the progression of PDAC.Keywords
Funding Information
- National Key Clinical Specialist Construction Programs of China (2013-544)
- National Nature Science Foundation of China (81472263)
- National Nature Science Foundation of China (81201651, 81472264)
- Tianjin Municipal Science and Technology Commission (14JCYBJC27500, 13JCYBJC37400)
This publication has 50 references indexed in Scilit:
- Clinical Significance and Revisiting the Meaning of CA 19-9 Blood Level Before and After the Treatment of Pancreatic Ductal Adenocarcinoma: Analysis of 1,446 Patients from the Pancreatic Cancer Cohort in a Single InstitutionPLOS ONE, 2013
- Human pancreatic adenocarcinoma contains a side population resistant to gemcitabineBMC Cancer, 2012
- MicroRNAs/TP53 feedback circuitry in glioblastoma multiformeProceedings of the National Academy of Sciences, 2012
- NGAL Expression Is Elevated in Both Colorectal Adenoma–Carcinoma Sequence and Cancer Progression and Enhances Tumorigenesis in Xenograft Mouse ModelsClinical Cancer Research, 2011
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic LeukemiaJAMA, 2011
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- A pancreas praecancerosisai: intraepithelialis neoplasia (PanIN) és intraductalis papillaris mucinosus neoplasia (IPMN)rMagyar Sebeszet, 2009
- Identification of hundreds of conserved and nonconserved human microRNAsNature Genetics, 2005
- Clinicopathological Correlates of Pancreatic Intraepithelial Neoplasia: A Comparative Analysis of 82 Cases With and 152 Cases Without Pancreatic Ductal AdenocarcinomaLaboratory Investigation, 2003
- BRCA2 Is Inactivated Late in the Development of Pancreatic Intraepithelial NeoplasiaThe American Journal of Pathology, 2000